IRIS
STROMILLO, MARIA LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.880
EU - Europa 4.683
AS - Asia 640
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
SA - Sud America 4
AF - Africa 3
Totale 11.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.867
GB - Regno Unito 1.773
IE - Irlanda 805
CN - Cina 475
SE - Svezia 437
UA - Ucraina 429
IT - Italia 345
FR - Francia 326
DE - Germania 239
FI - Finlandia 119
ES - Italia 52
SG - Singapore 52
RU - Federazione Russa 43
VN - Vietnam 41
BE - Belgio 29
NL - Olanda 17
TR - Turchia 16
MK - Macedonia 15
CA - Canada 11
CZ - Repubblica Ceca 10
HK - Hong Kong 10
PH - Filippine 9
JP - Giappone 7
GR - Grecia 6
IL - Israele 6
AU - Australia 5
EU - Europa 5
IN - India 5
IR - Iran 5
KR - Corea 5
HU - Ungheria 4
RS - Serbia 4
AL - Albania 3
AT - Austria 3
BG - Bulgaria 3
MA - Marocco 3
PL - Polonia 3
DK - Danimarca 2
ID - Indonesia 2
KZ - Kazakistan 2
MD - Moldavia 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BR - Brasile 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
IM - Isola di Man 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 11.222
Salva come PNG Salva come JPEG
Città #
Southend 1.639
Fairfield 959
Dublin 799
Ashburn 474
Chandler 469
Woodbridge 468
Menlo Park 439
Houston 377
Wilmington 377
Seattle 358
Jacksonville 354
Cambridge 331
Princeton 165
Ann Arbor 163
Siena 155
Nanjing 117
Beijing 106
Boardman 52
Málaga 51
San Mateo 51
Helsinki 48
San Diego 46
Dong Ket 40
Nanchang 37
New York 36
Lancaster 35
Shenyang 34
Moscow 29
Singapore 25
Düsseldorf 23
Norwalk 22
Tianjin 22
London 21
Florence 20
Changsha 19
Hebei 19
Brussels 18
Jiaxing 18
Kunming 18
Milan 17
Jinan 16
Dearborn 15
Los Angeles 14
Shanghai 13
Fremont 12
Izmir 12
San Francisco 10
Waanrode 10
Washington 10
Ningbo 9
Kilburn 8
Rome 8
Sacramento 8
Zhengzhou 8
Hangzhou 7
Pisa 7
Toronto 7
Phoenix 6
Renton 6
Skopje 6
Torino 6
Amsterdam 5
Boston 5
Brno 5
Chicago 5
Lanzhou 5
Munich 5
Redwood City 5
Venezia 5
Belgrade 4
Cedar Knolls 4
Central 4
Falls Church 4
Frankfurt am Main 4
Fuzhou 4
Genoa 4
Hong Kong 4
Parma 4
Saint Petersburg 4
Tappahannock 4
Villacidro 4
Bonndorf 3
Brdo 3
Caserta 3
Changchun 3
Edinburgh 3
General Trias 3
Gyomro 3
Haikou 3
Hefei 3
Hounslow 3
Lappeenranta 3
Monte Porzio Catone 3
Mountain View 3
New Bedfont 3
Norwich 3
Seodaemun-gu 3
Sofia 3
Tokyo 3
Acton 2
Totale 8.793
Salva come PNG Salva come JPEG
Nome #
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 220
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 205
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 201
Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28 187
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 186
null 182
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 179
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 171
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 167
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 164
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 164
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 162
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 160
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 158
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 156
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 154
Cortical lesions in radiologically isolated syndrome. 152
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 147
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 146
Assessing response to interferon-β in a multicenter dataset of patients with MS 145
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 144
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 144
Scoring treatment response in patients with relapsing multiple sclerosis 144
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study 144
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 142
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 141
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 141
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 141
Automated identification of brain new lesions in multiple sclerosis using subtraction images 140
Increased QT variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 140
Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis. 139
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 138
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study 135
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 133
Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation 132
MR evidence of structural and metabolic changes in brains of patients with Werner’s syndrome. 131
Impaired vasoreactivity in mildly disabled CADASIL patients 130
Refining response to treatment as defined by the Modified Rio Score 129
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 128
Deep gray matter volume loss drives disability worsening in multiple sclerosis 128
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 127
Rapidly progressive neurodegeneration in a case with the 7472insC mutation and the A7472C polymorphism in the mtDNA tRNA ser(UCN) gene. 126
Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. 125
Diffuse structural and metabolic brain changes in Fabry disease 123
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 123
Leukoencephalopathy as a rare complication of hepatitis C infection. 122
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 122
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 122
The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: A Screening Tool to Select Patients for NOTCH3 Gene Analysis. 122
Cortical functional reorganisation and its relationship with brain structural damage in patients with benign multiple sclerosis 121
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes 120
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 118
Post-stroke depression: Research methodology of a large multicentre observational study (DESTRO) 118
null 117
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. 117
Modelling the distribution of cortical lesions in multiple sclerosis 116
Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis 116
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 114
Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. 113
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course 113
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study 109
The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study 108
null 108
Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL: A Randomized Controlled Trial 107
Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. 106
Retinal nerve fibre layer thickness, lesional load and brain atrophy in patients with cerebral autosomal dominant arteriopathy with subcortical infarct and leucoencephalopathy (CADASIL) 104
Leukoencephalopathy, cerebral calcifications, and parenchimal cysts in two siblings. 104
null 102
APOE-{varepsilon}4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. 98
Imaging neuronal and axonal degeneration in multiple sclerosis. 94
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 94
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 93
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis 92
A comparison of cognitive performances between multiple sclerosis patients with pediatric- versus adult onset disease 91
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 87
null 84
Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy 83
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL, exon 2 mutation. 83
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 80
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis 79
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 78
Short-Term Combination of Glatiramer Acetate with IV Steroid Treatment Preceding Treatment with GA Alone Is Associated with early Suppression of MRI-disease activity in Patients with Relapsing Remitting Multiple Sclerosis 78
Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis 77
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 73
Efficacy and safety of intravenous immunoglobulin treatment in refractory Behcet's Disease with different organ involvement: a case series 67
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 63
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 59
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 56
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 56
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm 54
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis 45
Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 40
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 37
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 30
Hippocampal and deep gray matter nuclei atrophy is relevant for explaining cognitive impairment in MS: A multicenter study 26
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 25
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 24
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 19
Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients 19
Hippocampal atrophy in vascular MCI as biomarker of subclinical memory impairment 18
Totale 11.395
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.330 285 100 172 368 142 174 216 293 206 191 61 122
2020/20211.952 72 189 39 132 89 175 231 358 178 163 177 149
2021/20221.441 107 148 99 101 110 70 79 50 79 124 205 269
2022/20231.778 111 151 235 225 160 336 51 155 204 67 53 30
2023/20241.202 61 25 110 48 35 331 429 26 6 25 24 82
2024/202531 31 0 0 0 0 0 0 0 0 0 0 0
Totale 11.429